Cargando…

Insights into the Dual Activity of SIVmac239 Vif against Human and African Green Monkey APOBEC3G

Human immunodeficiency virus type 1 (HIV-1) Vif is essential for viral evasion of the host antiviral protein APOBEC3G (APO3G). The Vif protein from a distantly related African green monkey (Agm) simian immunodeficiency virus (SIVagm) is unable to suppress the antiviral activity of human APO3G but is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gaur, Ritu, Strebel, Klaus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506583/ https://www.ncbi.nlm.nih.gov/pubmed/23189135 http://dx.doi.org/10.1371/journal.pone.0048850

Ejemplares similares

HIV-1 Vif, APOBEC, and Intrinsic Immunity
por: Goila-Gaur, Ritu, et al.
Publicado: (2008)

Efficacy of vaccine-induced Vif-specific CTL responses against SIVmac239 infection: implications for antigen design in AIDS vaccines
por: Iwamoto, N, et al.
Publicado: (2012)

P03-08. Protection against SIVmac239 challenge in a rhesus macaque model conferred by a doxycycline dependent attenuated SIVmac239
por: Page, M, et al.
Publicado: (2009)

Immunogenicity of Seven New Recombinant Yellow Fever Viruses 17D Expressing Fragments of SIVmac239 Gag, Nef, and Vif in Indian Rhesus Macaques
por: Martins, Mauricio A., et al.
Publicado: (2013)

Encapsidation of APOBEC3G into HIV-1 virions involves lipid raft association and does not correlate with APOBEC3G oligomerization
por: Khan, Mohammad A, et al.
Publicado: (2009)

Vaccine protection against rectal acquisition of SIVmac239 in rhesus macaques
por: Gonzalez-Nieto, Lucas, et al.
Publicado: (2019)

Longitudinal white matter alterations in SIVmac239-infected rhesus monkeys with and without regular cART treatment
por: Liu, Jiaojiao, et al.
Publicado: (2023)

Evolution of SIVmac239 following serial passaging in humanized mice
por: Curlin, James Z., et al.
Publicado: (2022)

Small molecules that inhibit Vif-induced degradation of APOBEC3G
por: Matsui, Masashi, et al.
Publicado: (2014)

Structure of the Vif-binding domain of the antiviral enzyme APOBEC3G
por: Kouno, Takahide, et al.
Publicado: (2015)

Regulatory role of upstream AUG codons within the SIVmac239 genome
por: van der Velden, Gisela J, et al.
Publicado: (2011)

Structural insights into RNA bridging between HIV-1 Vif and antiviral factor APOBEC3G
por: Kouno, Takahide, et al.
Publicado: (2023)

HIV-1 Vif and APOBEC3G: Multiple roads to one goal
por: Goncalves, Joao, et al.
Publicado: (2004)

Towards Inhibition of Vif-APOBEC3G Interaction: Which Protein to Target?
por: Cadima-Couto, Iris, et al.
Publicado: (2010)

Degradation-Independent Inhibition of APOBEC3G by the HIV-1 Vif Protein
por: Stupfler, Benjamin, et al.
Publicado: (2021)

The structural basis for HIV-1 Vif antagonism of human APOBEC3G
por: Li, Yen-Li, et al.
Publicado: (2023)

Generation and characterization of a SIVmac239 clone corrected at four suboptimal nucleotides
por: Fennessey, Christine M, et al.
Publicado: (2015)

Analysis of the contribution of cellular and viral RNA to the packaging of APOBEC3G into HIV-1 virions
por: Khan, Mohammad A, et al.
Publicado: (2007)

Dual Functionality of HIV-1 Vif in APOBEC3 Counteraction and Cell Cycle Arrest
por: Salamango, Daniel J., et al.
Publicado: (2021)

APOBEC3G & HTLV-1: Inhibition without deamination
por: Strebel, Klaus
Publicado: (2005)

Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activity
por: Goila-Gaur, Ritu, et al.
Publicado: (2007)

T cell response specificity and magnitude against SIVmac239 are not concordant in major histocompatibility complex-matched animals
por: Cain, Brian T, et al.
Publicado: (2013)

Suppression of APOBEC3-mediated restriction of HIV-1 by Vif
por: Feng, Yuqing, et al.
Publicado: (2014)

Host Restriction of Lentiviruses and Viral Countermeasures: APOBEC3 and Vif
por: Jónsson, Stefán R., et al.
Publicado: (2013)

HIV-1 Vif binds to APOBEC3G mRNA and inhibits its translation
por: Mercenne, Gaëlle, et al.
Publicado: (2010)

Development of Lentiviral Vectors for HIV-1 Gene Therapy with Vif-Resistant APOBEC3G
por: Delviks-Frankenberry, Krista A., et al.
Publicado: (2019)

Dendritic cell subsets dynamics and cytokine production in SIVmac239-infected Chinese rhesus macaques
por: Xia, Hou-Jun, et al.
Publicado: (2010)

Non-neutralizing Antibodies May Contribute to Suppression of SIVmac239 Viremia in Indian Rhesus Macaques
por: Pedreño-Lopez, Nuria, et al.
Publicado: (2021)

Production of infectious human immunodeficiency virus type 1 does not require depletion of APOBEC3G from virus-producing cells
por: Kao, Sandra, et al.
Publicado: (2004)

Aromatic disulfides as potential inhibitors against interaction between deaminase APOBEC3G and HIV infectivity factor: Inhibitors of interaction between APOBEC3G and Vif
por: Yan, Xiaoxuan, et al.
Publicado: (2022)

Determinants of FIV and HIV Vif sensitivity of feline APOBEC3 restriction factors
por: Zhang, Zeli, et al.
Publicado: (2016)

AAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing Activity
por: Fuchs, Sebastian P., et al.
Publicado: (2015)

Potent restriction of HIV-1 and SIV(mac239) Replication by African Green Monkey TRIM5α
por: Coren, Lori V, et al.
Publicado: (2015)

APOBEC3G encapsidation into HIV-1 virions: which RNA is it?
por: Strebel, Klaus, et al.
Publicado: (2008)

Definition of the interacting interfaces of Apobec3G and HIV-1 Vif using MAPPIT mutagenesis analysis
por: Lavens, Delphine, et al.
Publicado: (2010)

Definition of the interacting interfaces of Apobec3G and HIV-1 Vif using MAPPIT mutagenesis analysis
por: Lavens, Delphine, et al.
Publicado: (2010)

Rapid, repeated, low-dose challenges with SIVmac239 infect animals in a condensed challenge window
por: Greene, Justin M, et al.
Publicado: (2014)

Parasites may exit immunocompromised northern pig-tailed macaques (Macaca leonina) infected with SIVmac239
por: Song, Tian-Zhang, et al.
Publicado: (2018)

Host AKT-mediated phosphorylation of HIV-1 accessory protein Vif potentiates infectivity via enhanced degradation of the restriction factor APOBEC3G
por: Raja, Rameez, et al.
Publicado: (2022)

Degradation of the cancer genomic DNA deaminase APOBEC3B by SIV Vif
por: Land, Allison M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vqbgocm745neqvlgdj5jsg2vei